HER2 Support Group Forums - View Single Post - approximately 85% of women with this disease receive adjuvant chemotherapy unnecessar

Christine MH-UK · 12-22-2005, 07:12 AM

I am not so sure that this applies to most HER2+ve patients, since this test is "indicated for patients with newly diagnosed, stage I or II, node-negative, estrogen-receptor positive breast cancer." Still, anything that matches patients to treatments better is welcome.

12-22-2005, 07:12 AM	#2
Christine MH-UK Senior Member Join Date: Sep 2005 Posts: 414	Applies to a certain group of patients I am not so sure that this applies to most HER2+ve patients, since this test is "indicated for patients with newly diagnosed, stage I or II, node-negative, estrogen-receptor positive breast cancer." Still, anything that matches patients to treatments better is welcome.